PRME Stock Summary and Trading Ideas (Prime Medicine | NASDAQ:PRME)

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

What symbol and exchange does Prime Medicine shares trade?

Prime Medicine trades on the NASDAQ stock market under the symbol PRME.

What is Prime Medicine stock price doing today?

As of August 21, 2026, PRME stock price climbed to $3.39 with 3,517,271 million shares trading.

What is Prime Medicine's Beta?

PRME has a beta of 2.06, meaning it tends to be more sensitive to market movements. PRME has a correlation of 0.10 to the broad based SPY ETF.

How much is Prime Medicine worth?

PRME has a market cap of $614.87 million. This is considered a Small Cap stock.

How much money does Prime Medicine make?

Last quarter Prime Medicine reported $1 million in Revenue and -$.24 earnings per share. This fell short of revenue expectation by $-610,072 and exceeded earnings estimates by $.01.

What is the highest and lowest price Prime Medicine traded in the last 3 year period?

In the last 3 years, PRME traded as high as $13.60 and as low as $1.11.

What are the top ETFs holding Prime Medicine?

The top ETF exchange traded funds that PRME belongs to (by Net Assets): ARKG, XBI, VTI, IWM, VXF.

Is Prime Medicine (PRME) a good investment?

PRME has underperformed the market in the last year with a return of +5.3%, while SPY returned +21.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PRME shares. However, PRME has outperformed the market in the last 3 month and 2 week periods, returning +14.9% and +10.1%, while SPY returned +3.4% and -1.0%, respectively. This indicates PRME has been having a stronger performance recently.

What are the support and resistance levels for Prime Medicine (PRME)?

PRME support price is $3.10 and resistance is $3.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRME shares will trade within this expected range on the day.